BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

498 related articles for article (PubMed ID: 17601799)

  • 1. TGF-beta1 stimulates human AT1 receptor expression in lung fibroblasts by cross talk between the Smad, p38 MAPK, JNK, and PI3K signaling pathways.
    Martin MM; Buckenberger JA; Jiang J; Malana GE; Knoell DL; Feldman DS; Elton TS
    Am J Physiol Lung Cell Mol Physiol; 2007 Sep; 293(3):L790-9. PubMed ID: 17601799
    [TBL] [Abstract][Full Text] [Related]  

  • 2. C-Jun-NH2-terminal kinase mediates expression of connective tissue growth factor induced by transforming growth factor-beta1 in human lung fibroblasts.
    Utsugi M; Dobashi K; Ishizuka T; Masubuchi K; Shimizu Y; Nakazawa T; Mori M
    Am J Respir Cell Mol Biol; 2003 Jun; 28(6):754-61. PubMed ID: 12760970
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tissue-specific mechanisms for CCN2/CTGF persistence in fibrotic gingiva: interactions between cAMP and MAPK signaling pathways, and prostaglandin E2-EP3 receptor mediated activation of the c-JUN N-terminal kinase.
    Black SA; Palamakumbura AH; Stan M; Trackman PC
    J Biol Chem; 2007 May; 282(21):15416-29. PubMed ID: 17428796
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Glycosyltransferases and glycosaminoglycans in bleomycin and transforming growth factor-β1-induced pulmonary fibrosis.
    Venkatesan N; Tsuchiya K; Kolb M; Farkas L; Bourhim M; Ouzzine M; Ludwig MS
    Am J Respir Cell Mol Biol; 2014 Mar; 50(3):583-94. PubMed ID: 24127863
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Induction of cardiac fibroblast lysyl oxidase by TGF-β1 requires PI3K/Akt, Smad3, and MAPK signaling.
    Voloshenyuk TG; Landesman ES; Khoutorova E; Hart AD; Gardner JD
    Cytokine; 2011 Jul; 55(1):90-7. PubMed ID: 21498085
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Endothelin-1 and transforming growth factor-beta1 independently induce fibroblast resistance to apoptosis via AKT activation.
    Kulasekaran P; Scavone CA; Rogers DS; Arenberg DA; Thannickal VJ; Horowitz JC
    Am J Respir Cell Mol Biol; 2009 Oct; 41(4):484-93. PubMed ID: 19188658
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inhibition of transforming growth factor (TGF)-beta1-induced extracellular matrix with a novel inhibitor of the TGF-beta type I receptor kinase activity: SB-431542.
    Laping NJ; Grygielko E; Mathur A; Butter S; Bomberger J; Tweed C; Martin W; Fornwald J; Lehr R; Harling J; Gaster L; Callahan JF; Olson BA
    Mol Pharmacol; 2002 Jul; 62(1):58-64. PubMed ID: 12065755
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Angiotensin II activates connective tissue growth factor and induces extracellular matrix changes involving Smad/activation and p38 mitogen-activated protein kinase signalling pathways in human dermal fibroblasts.
    Zhang GY; Li X; Yi CG; Pan H; He GD; Yu Q; Jiang LF; Xu WH; Li ZJ; Ding J; Lin DS; Gao WY
    Exp Dermatol; 2009 Nov; 18(11):947-53. PubMed ID: 19397700
    [TBL] [Abstract][Full Text] [Related]  

  • 9. TGF-β1 induces tissue factor expression in human lung fibroblasts in a PI3K/JNK/Akt-dependent and AP-1-dependent manner.
    Wygrecka M; Zakrzewicz D; Taborski B; Didiasova M; Kwapiszewska G; Preissner KT; Markart P
    Am J Respir Cell Mol Biol; 2012 Nov; 47(5):614-27. PubMed ID: 22771387
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Angiotensin II increases periostin expression via Ras/p38 MAPK/CREB and ERK1/2/TGF-β1 pathways in cardiac fibroblasts.
    Li L; Fan D; Wang C; Wang JY; Cui XB; Wu D; Zhou Y; Wu LL
    Cardiovasc Res; 2011 Jul; 91(1):80-9. PubMed ID: 21367774
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tacrolimus abrogates TGF-β1-induced type I collagen production in normal human fibroblasts through suppressing p38MAPK signalling pathway: implications on treatment of chronic atopic dermatitis lesions.
    Lan CC; Fang AH; Wu PH; Wu CS
    J Eur Acad Dermatol Venereol; 2014 Feb; 28(2):204-15. PubMed ID: 23301526
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inhibition of p38 mitogen-activated protein kinase and transforming growth factor-beta1/Smad signaling pathways modulates the development of fibrosis in adriamycin-induced nephropathy.
    Li J; Campanale NV; Liang RJ; Deane JA; Bertram JF; Ricardo SD
    Am J Pathol; 2006 Nov; 169(5):1527-40. PubMed ID: 17071578
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Transforming growth factor type beta 1 increases the expression of angiotensin II receptor type 2 by a SMAD- and p38 MAPK-dependent mechanism in skeletal muscle.
    Painemal P; Acuña MJ; Riquelme C; Brandan E; Cabello-Verrugio C
    Biofactors; 2013; 39(4):467-75. PubMed ID: 23460581
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mechanisms of induction of airway smooth muscle hyperplasia by transforming growth factor-beta.
    Xie S; Sukkar MB; Issa R; Khorasani NM; Chung KF
    Am J Physiol Lung Cell Mol Physiol; 2007 Jul; 293(1):L245-53. PubMed ID: 17468136
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Follistatin-Like 1 Promotes Bleomycin-Induced Pulmonary Fibrosis through the Transforming Growth Factor Beta 1/Mitogen-Activated Protein Kinase Signaling Pathway.
    Jin YK; Li XH; Wang W; Liu J; Zhang W; Fang YS; Zhang ZF; Dai HP; Ning W; Wang C
    Chin Med J (Engl); 2018 Aug; 131(16):1917-1925. PubMed ID: 30082522
    [TBL] [Abstract][Full Text] [Related]  

  • 16. TGF-beta inhibits Ang II-induced MAPK p44/42 signaling in vascular smooth muscle cells by Ang II type 1 receptor downregulation.
    Meijering BD; van der Wouden EA; Pelgröm V; Henning RH; Sharma K; Deelman LE
    J Vasc Res; 2009; 46(5):459-68. PubMed ID: 19204403
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Angiotensin II activates the Smad pathway in vascular smooth muscle cells by a transforming growth factor-beta-independent mechanism.
    Rodríguez-Vita J; Sánchez-López E; Esteban V; Rupérez M; Egido J; Ruiz-Ortega M
    Circulation; 2005 May; 111(19):2509-17. PubMed ID: 15883213
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Activation of the pro-survival phosphatidylinositol 3-kinase/AKT pathway by transforming growth factor-beta1 in mesenchymal cells is mediated by p38 MAPK-dependent induction of an autocrine growth factor.
    Horowitz JC; Lee DY; Waghray M; Keshamouni VG; Thomas PE; Zhang H; Cui Z; Thannickal VJ
    J Biol Chem; 2004 Jan; 279(2):1359-67. PubMed ID: 14576166
    [TBL] [Abstract][Full Text] [Related]  

  • 19. TGF-β1/ALK5-induced monocyte migration involves PI3K and p38 pathways and is not negatively affected by diabetes mellitus.
    Olieslagers S; Pardali E; Tchaikovski V; ten Dijke P; Waltenberger J
    Cardiovasc Res; 2011 Aug; 91(3):510-8. PubMed ID: 21478266
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Angiotensin II induces thrombospondin-1 production in human mesangial cells via p38 MAPK and JNK: a mechanism for activation of latent TGF-beta1.
    Naito T; Masaki T; Nikolic-Paterson DJ; Tanji C; Yorioka N; Kohno N
    Am J Physiol Renal Physiol; 2004 Feb; 286(2):F278-87. PubMed ID: 14583433
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 25.